
    
      A Bioequivalence Study of the Fixed Dose Combination Dapagliflozin/Metformin Tablet (5.0
      mg/850 mg) Relative to a 5.0 mg Dapagliflozin Tablet and an 850 mg Metformin (GlucophageÂ®
      Marketed in Canada by Sanofi-Aventis) Tablet Co-Administered to Healthy Subjects in the
      Fasted and Fed States
    
  